Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) - Stock Prices, Stock Peers & Analysis

Home
603520.SS

Company Name	Zhejiang Starry Pharmaceutical Co.,Ltd.
Symbol	603520.SS
Currency	CNY
Price	10.42
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	4,568,232,200
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	1.61%
52-week-range	7.32 - 11.35
Industry	Drug Manufacturers—Specialty & Generic
Sector	Healthcare
CEO	Mr. Jian Hu
Website	https://www.starrypharm.com

An error occurred while fetching data.

About Zhejiang Starry Pharmaceutical Co.,Ltd.

Zhejiang Starry Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally. Its contrast agent products include iohexol, iohexol hydrolysate, iohexol iodide, ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate; and fluoroquinolones